IAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across four countries.

They looked towards the interferon-gamma release assay (IGRA), a blood test initially developed to diagnose bTB in cattle. It works by measuring the levels of interferon-gamma (IFN-γ), a molecule ...

A 15-year study by Kaiser Permanente Northern California reveals significant gaps in LTBI testing practices, highlighting the need for targeted strategies to prevent active TB cases.